Preclinical Systolic and Diastolic Dysfunctions in Metabolically Healthy and Unhealthy Obese Individuals
Yi‐Chih Wang(Brigham and Women's Hospital), Jennifer E. Ho(Massachusetts General Hospital), Courtney Donohue(Brigham and Women's Hospital), Deepa M. Gopal(Boston University), Rajalakshmi Santhanakrishnan(Cardiovascular Research Center), Wilson S. Colucci(Boston University), Nir Ayalon(Boston University), Jill Downing(Boston University), Noyan Gokce(Boston University), Alejandro J. Perez(Brigham and Women's Hospital), Harpaul Sandhu(Brigham and Women's Hospital), Chang‐seng Liang(Neusoft (China))
Cited by 92
Related Papers
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
|Circulation|2023|1.7k
Targeted Anticytokine Therapy in Patients With Chronic Heart Failure
|Circulation|2004|1.2k
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
|Circulation|2023|1.1k
Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure
|New England Journal of Medicine|2000|908
Mitochondrial function as a therapeutic target in heart failure
|Nature Reviews Cardiology|2016|786